NASDAQ:MDSO - Medidata Solutions Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$69.27 -0.34 (-0.49 %)
(As of 10/18/2018 05:43 AM ET)
Previous Close$69.61
Today's Range$68.54 - $70.26
52-Week Range$59.60 - $88.87
Volume1.50 million shs
Average Volume635,084 shs
Market Capitalization$4.37 billion
P/E Ratio81.53
Dividend YieldN/A
Beta1.44
Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner and ongoing support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force, as well as through relationships with contract research organizations (CROs) and other strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and CROs and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.

Receive MDSO News and Ratings via Email

Sign-up to receive the latest news and ratings for MDSO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Prepackaged software
Sub-IndustryHealth Care Technology
SectorMedical
SymbolNASDAQ:MDSO
CUSIP58471A10
Phone212-918-1800

Debt

Debt-to-Equity Ratio0.16
Current Ratio1.41
Quick Ratio1.41

Price-To-Earnings

Trailing P/E Ratio81.53
Forward P/E Ratio87.68
P/E Growth4.59

Sales & Book Value

Annual Sales$545.53 million
Price / Sales7.58
Cash Flow$1.4676 per share
Price / Cash47.20
Book Value$8.51 per share
Price / Book8.14

Profitability

EPS (Most Recent Fiscal Year)$0.85
Net Income$44.38 million
Net Margins9.13%
Return on Equity11.37%
Return on Assets5.63%

Miscellaneous

Employees1,680
Outstanding Shares59,680,000
Market Cap$4.37 billion

Medidata Solutions (NASDAQ:MDSO) Frequently Asked Questions

What is Medidata Solutions' stock symbol?

Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."

How were Medidata Solutions' earnings last quarter?

Medidata Solutions Inc (NASDAQ:MDSO) announced its quarterly earnings results on Tuesday, July, 24th. The company reported $0.43 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.39 by $0.04. The firm had revenue of $155.90 million for the quarter, compared to analyst estimates of $155.86 million. Medidata Solutions had a net margin of 9.13% and a return on equity of 11.37%. The business's revenue for the quarter was up 14.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.31 EPS. View Medidata Solutions' Earnings History.

When is Medidata Solutions' next earnings date?

Medidata Solutions is scheduled to release their next quarterly earnings announcement on Thursday, October 18th 2018. View Earnings Estimates for Medidata Solutions.

How can I listen to Medidata Solutions' earnings call?

Medidata Solutions will be holding an earnings conference call on Thursday, October 18th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8773032528.

What price target have analysts set for MDSO?

11 brokerages have issued twelve-month price objectives for Medidata Solutions' shares. Their forecasts range from $80.00 to $98.00. On average, they expect Medidata Solutions' stock price to reach $88.3636 in the next year. This suggests a possible upside of 27.6% from the stock's current price. View Analyst Price Targets for Medidata Solutions.

What is the consensus analysts' recommendation for Medidata Solutions?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 4 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medidata Solutions.

Who are some of Medidata Solutions' key competitors?

Who are Medidata Solutions' key executives?

Medidata Solutions' management team includes the folowing people:
  • Mr. Tarek A. Sherif, Co-Founder, Chairman & CEO (Age 56)
  • Mr. Glen M. De Vries, Co-Founder, Pres & Director (Age 46)
  • Mr. Rouven Bergmann, CFO & Chief Accounting Officer (Age 45)
  • Mr. Michael I. Otner, Exec. VP, Gen. Counsel & Sec. (Age 47)
  • Mr. Michael Pray, Exec. VP & GM of Global Sales (Age 52)

Who are Medidata Solutions' major shareholders?

Medidata Solutions' stock is owned by a number of of retail and institutional investors. Top institutional investors include Nikko Asset Management Americas Inc. (1.20%), Copper Rock Capital Partners LLC (0.51%), Summit Creek Advisors LLC (0.19%), Sumitomo Mitsui Asset Management Company LTD (0.07%), KAMES CAPITAL plc (0.05%) and Bank of Montreal Can (0.05%). Company insiders that own Medidata Solutions stock include Carlos Dominguez, Eileen Schloss, Lee Shapiro, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann, Steven Isaac Hirschfeld, Tarek Sherif and Vries Glen Michael De. View Institutional Ownership Trends for Medidata Solutions.

Which institutional investors are selling Medidata Solutions stock?

MDSO stock was sold by a variety of institutional investors in the last quarter, including Summit Creek Advisors LLC and Sumitomo Mitsui Asset Management Company LTD. Company insiders that have sold Medidata Solutions company stock in the last year include Carlos Dominguez, Lee Shapiro, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Insider Buying and Selling for Medidata Solutions.

Which institutional investors are buying Medidata Solutions stock?

MDSO stock was acquired by a variety of institutional investors in the last quarter, including Nikko Asset Management Americas Inc., Copper Rock Capital Partners LLC, Bank of Montreal Can, KAMES CAPITAL plc and NJ State Employees Deferred Compensation Plan. View Insider Buying and Selling for Medidata Solutions.

How do I buy shares of Medidata Solutions?

Shares of MDSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medidata Solutions' stock price today?

One share of MDSO stock can currently be purchased for approximately $69.27.

How big of a company is Medidata Solutions?

Medidata Solutions has a market capitalization of $4.37 billion and generates $545.53 million in revenue each year. The company earns $44.38 million in net income (profit) each year or $0.85 on an earnings per share basis. Medidata Solutions employs 1,680 workers across the globe.

What is Medidata Solutions' official website?

The official website for Medidata Solutions is http://www.mdsol.com.

How can I contact Medidata Solutions?

Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]com.


MarketBeat Community Rating for Medidata Solutions (NASDAQ MDSO)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  415 (Vote Outperform)
Underperform Votes:  307 (Vote Underperform)
Total Votes:  722
MarketBeat's community ratings are surveys of what our community members think about Medidata Solutions and other stocks. Vote "Outperform" if you believe MDSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDSO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel